×
About 118,893 results

ALLMedicine™ Prostate Cancer Center

Research & Reviews  37,228 results

Crotonianoids A-C, Three Unusual Tigliane Diterpenoids from the Seeds of Croton tiglium...
https://doi.org/10.1021/acs.joc.2c01024
The Journal of Organic Chemistry; Hu R, Huang JL et. al.

Jun 28th, 2022 - Crotonianoids A-C (1-3), three unusual tigliane diterpenoids, were isolated from the seeds of Croton tiglium. Compound 1 is a 13,14:13,15-diseco-tigliane featuring a unique spiro[bicyclo[5.3.0]decane-2,5'-2'(3'H,4'H)-furanone] core; 2 is a 13,15-s...

The impact of radical prostatectomy on the social well-being of prostate cancer survivo...
https://doi.org/10.1111/ecc.13630
European Journal of Cancer Care; Eymech O, Brunckhorst O et. al.

Jun 28th, 2022 - The impact of radical prostatectomy on the social well-being of survivors remains poorly understood. This meta-synthesis therefore aimed to integrate the findings of qualitative research evaluating the impact of surgery on the patient relationship...

Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate canc...
https://doi.org/10.1111/cas.15473
Cancer Science; Kamisawa K, Kosaka T et. al.

Jun 28th, 2022 - The purpose of this study was to investigate factors predicting the sensitivity to cabazitaxel therapy in metastatic castration-resistant prostate cancer (mCRPC) patients with phosphatase and tensin homolog deleted from chromosome 10 (PTEN) altera...

Effects of marital status on survival of retroperitoneal liposarcomas stratified by age...
https://doi.org/10.1002/cam4.4962
Cancer Medicine; Li Y, Wu G et. al.

Jun 28th, 2022 - Previous studies have shown that marital status is associated with survival in patients with a variety of cancer types, including lung cancer, prostate cancer, and bladder cancer. However, to date, the impact of marital status on the survival of p...

Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive pros...
https://doi.org/10.1158/2159-8290.CD-21-0576
Cancer Discovery; Linder S, Hoogstraat M et. al.

Jun 28th, 2022 - In prostate cancer, androgen receptor (AR)-targeting agents are very effective in various disease stages. However, therapy resistance inevitably occurs and little is known about how tumor cells adapt to bypass AR suppression. Here, we performed in...

see more →

Guidelines  81 results

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate ...
https://doi.org/10.1097/COC.0000000000000915
American Journal of Clinical Oncology; Bittner NHJ, Cox BW et. al.

May 20th, 2022 - The American College of Radiology (ACR), American Brachytherapy Society (ABS), and American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for transperineal permanent brachytherapy of prostate cancer...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radi...
https://doi.org/10.1097/JU.0000000000002759
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part III of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of radiation and offering several future directions of further relevant study i...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Activ...
https://doi.org/10.1097/JU.0000000000002758
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part II of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of active surveillance and surgery as well as follow-up for patients after prima...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk A...
https://doi.org/10.1097/JU.0000000000002757
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part I of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment, staging, and risk-based management in patients diagnosed with clinically lo...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Endorsed by SUO
https://www.auanet.org/guidelines/guidelines/clinically-localized-prostate-cancer-aua/astro-guideline-2022
Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 10th, 2022 - The recommendations discussed herein for the management of clinically localized prostate cancer provide a framework stratified by risk to facilitate care decisions and guide clinicians in the implementation of selected management options.

see more →

Drugs  213 results see all →

Clinicaltrials.gov  4,866 results

Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04808427

Jun 24th, 2022 - Background: Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostate cancers prove to be small, low grade, and noninvasive and they appear to pose little risk to the life or health o...

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03173924

Jun 24th, 2022 - Background: The objective of this study is to evaluate a radiolabeled urea-based small molecule inhibitor of prostate-specific membrane antigen (PSMA), [18F] DCFPyL (DCFPyL) PET/CT (or PET/MRI imaging if available) for detection of metastatic pros...

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04843319

Jun 24th, 2022 - This study is a multicenter, randomized, open-label, dose finding study of VERU-100 to attain and maintain serum total testosterone levels within castrate range (<50ng/dL) in men with advanced prostate cancer. Stage 1 of the study will assess the ...

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03181867

Jun 24th, 2022 - Background Prostate cancer (PCa) is the second leading cause of cancer death in American men. Patients with high risk but apparently localized disease are often understaged because disease beyond the prostate is not well detected and thus leads to...

Vaccine Response With NT-I7
https://clinicaltrials.gov/ct2/show/NCT04054752

Jun 24th, 2022 - Background: Interleukin-7 is a homeostatic cytokine with a critical role in lymphoid homeostasis through which it exerts its immune-restorative effects, particularly re-expansion of the na(SqrRoot) ve and memory T-cell subsets. The clinical implic...

see more →

News  5,097 results

Number of US Cancer Survivors Grew to Over 18 Million
https://www.medscape.com/viewarticle/976225

Jun 27th, 2022 - Of more than 18 million Americans who have a history of cancer, two thirds were aged 65 or older as of January 1 of this year, according to a joint report by the American Cancer Society (ACS) and the National Cancer Institute (NCI). This number ha...

Fast Five Quiz: Advanced and Metastatic Prostate Cancer Presentation and Diagnosis
https://www.medscape.com/viewarticle/921119

Jun 27th, 2022 - Despite improvements in detection and treatment, prostate cancer remains a significant cause of morbidity and mortality worldwide, and its incidence is increasing. Globally, over 1.4 million cases of prostate cancer were diagnosed in 2020. Althoug...

Fast Five Quiz: Metastatic Hormone-Sensitive Prostate Cancer Treatment
https://www.medscape.com/viewarticle/921254

Jun 27th, 2022 - The incidence of metastatic hormone-sensitive prostate cancer (mHSPC) has significantly increased in recent years, in part due to advancements in imaging technology. Men with metastatic prostate cancer who have not received prior treatment with an...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://reference.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://www.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

see more →

Patient Education  72 results see all →